T1	PROC 46 74	Estudio de extensión abierto
T2	Date 95 108	a largo plazo
T3	CHEM 112 134	treprostinil palmitilo
T4	Form 135 148	en polvo para
T5	Route 149 159	inhalación
T6	LIVB 163 172	pacientes
#1	AnnotatorNotes T6	C0030705; Patients; Patient or Disabled Group
T7	DISO 177 207	hipertensión arterial pulmonar
#2	AnnotatorNotes T7	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T8	PROC 230 258	Estudio de extensión abierto
T9	PROC 264 310	evaluar la seguridad, tolerabilidad y eficacia
T10	Date 319 332	a largo plazo
T11	CHEM 336 358	treprostinil palmitilo
T12	Form 359 372	en polvo para
T13	Route 373 383	inhalación
T14	LIVB 387 396	pacientes
#3	AnnotatorNotes T14	C0030705; Patients; Patient or Disabled Group
T15	DISO 401 431	hipertensión arterial pulmonar
#4	AnnotatorNotes T15	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T16	LIVB 455 468	Participantes
T17	DISO 473 502	tension sanguínea alta en las
T18	ANAT 503 527	arterias de los pulmones
T19	LIVB 554 567	Participantes
T20	DISO 572 602	hipertensión arterial pulmonar
#5	AnnotatorNotes T20	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T21	LIVB 632 645	Participantes
T22	PROC 665 671	visita
T23	PROC 682 693	tratamiento
#6	AnnotatorNotes T23	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T24	PROC 777 781	TPPI
T25	DISO 790 793	HAP
#7	AnnotatorNotes T25	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T26	LIVB 799 812	participantes
T27	Neg_cue 841 843	no
T28	Negated 851 861	disponible
T29	Date 903 915	preinclusión
T30	Duration 958 964	un año
T31	PROC 971 977	visita
T32	PROC 988 999	tratamiento
#8	AnnotatorNotes T32	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T33	Date 1015 1027	preinclusión
T34	PROC 1033 1058	Evaluaciones de selección
T35	Duration 1145 1159	más de 30 días
T36	PROC 1169 1175	visita
T37	Date 1269 1281	preinclusión
T38	CHEM 1286 1290	TPPI
T39	DISO 1299 1302	HAP
#9	AnnotatorNotes T39	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T40	PROC 1328 1352	consentimiento informado
#10	AnnotatorNotes T40	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T41	LIVB 1391 1404	Participantes
T42	DISO 1434 1451	hipersensibilidad
#11	AnnotatorNotes T42	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding | C0585186; Cutaneous hypersensitivity; Disease or Syndrome
T43	DISO 1454 1485	reacción adversa al medicamento
T44	PROC 1560 1564	TPPI
T45	DISO 1573 1576	HAP
#12	AnnotatorNotes T45	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T46	LIVB 1601 1613	investigador
#13	AnnotatorNotes T46	C0035173; Research Personnel; Professional or Occupational Group
T47	Spec_cue 1615 1621	podría
T48	PROC 1634 1658	continuar el tratamiento
T49	CHEM 1663 1667	TPPI
T50	Spec_cue 1668 1673	puede
T51	Speculated 1687 1693	riesgo
T52	Speculated 1694 1705	irrazonable
T53	LIVB 1714 1726	participante
T54	PROC 1744 1769	administración parenteral
T55	Route 1759 1769	parenteral
T56	CHEM 1773 1798	análogos de prostaciclina
T57	CHEM 1813 1816	TRE
T58	CHEM 1818 1830	epoprostenol
#14	AnnotatorNotes T58	C0033567; epoprostenol; Biologically Active Substance · Organic Chemical · Pharmacologic Substance
T59	PROC 1915 1919	TPPI
T60	CHEM 1945 1970	análogos de prostaciclina
T61	Route 1971 1980	inhalados
T62	PROC 1995 1998	TRE
#15	AnnotatorNotes T62	C0014935; Estrogen Replacement Therapy; Therapeutic or Preventive Procedure
T63	CHEM 2000 2006	Tyvaso
T64	CHEM 2011 2019	iloprost
#16	AnnotatorNotes T64	C0079594; iloprost; Organic Chemical · Pharmacologic Substance
T65	CHEM 2023 2055	análogos orales de prostaciclina
T66	Route 2032 2038	orales
T67	PROC 2070 2073	TRE
#17	AnnotatorNotes T67	C0014935; Estrogen Replacement Therapy; Therapeutic or Preventive Procedure
T68	CHEM 2075 2084	Orenitram
T69	CHEM 2090 2112	agonistas del receptor
T70	CHEM 2127 2136	selexipag
#18	AnnotatorNotes T70	C2000145; selexipag; Organic Chemical · Pharmacologic Substance
T71	Duration 2154 2162	24 horas
T72	PROC 2186 2212	administración del fármaco
T73	PHYS 2229 2237	Embarazo
#19	AnnotatorNotes T73	C0032961; Pregnancy; Organism Function
T74	PHYS 2240 2249	lactancia
#20	AnnotatorNotes T74	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T75	DISO 2264 2293	afección médica o psicológica
T76	LIVB 2381 2393	investigador
#21	AnnotatorNotes T76	C0035173; Research Personnel; Professional or Occupational Group
T77	DISO 2407 2417	enfermedad
#22	AnnotatorNotes T77	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T78	Spec_cue 2458 2463	pueda
T79	Speculated 2477 2483	riesgo
T80	Speculated 2484 2495	irrazonable
T81	LIVB 2504 2516	participante
